(Q44514117)

3 December 2017

title

ACE DD genotype: an independent predisposition factor to venous thromboembolism (English)

1 reference

3 December 2017

3

1 reference

3 December 2017

5

1 reference

3 December 2017

8

1 reference

3 December 2017

Fatini C

1

1 reference

3 December 2017

Gensini F

2

1 reference

3 December 2017

Battaglini B

4

1 reference

3 December 2017

Fedi S

6

1 reference

3 December 2017

Brunelli T

7

1 reference

3 December 2017

Conti AA

9

1 reference

3 December 2017

Gensini GF

10

1 reference

3 December 2017

Abbate R

11

1 reference

3 December 2017

publication date

1 August 2003

1 reference

European Journal of Clinical Investigation

3 December 2017

published in

1 reference

3 December 2017

volume

33

1 reference

3 December 2017

issue

8

1 reference

3 December 2017

page(s)

642-647

1 reference

Mutation in blood coagulation factor V associated with resistance to activated protein C.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

Relation of three genetic traits to venous thrombosis in an African-American population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

Plasma Activity and Insertion/Deletion Polymorphism of Angiotensin I–Converting Enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

Risk of venous thromboembolism associated with the insertion/deletion polymorphism in the angiotensin-converting enzyme gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

Effect of the angiotensin-converting enzyme gene deletion polymorphism on the risk of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

High levels of coagulation factor XI as a risk factor for venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

Captopril administration reduces thrombus formation and surface expression of platelet glycoprotein IIb/IIa in early postmyocardial infarction stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01185.X

10.1046/J.1365-2362.2003.01185.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference